Pharmadrug Inc. (CSE: PHRX)

Pharmadrug Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.13	0.41	0.01	0.96	2.13	0.07
Short-Term Investments	-	0.01	0.32	0.34	2.27	0.44
Cash & Short-Term Investments	0.13	0.42	0.33	1.3	4.4	0.51
Cash Growth	-32.00%	28.50%	-74.58%	-70.59%	757.33%	231.19%
Accounts Receivable	-	-	-	0.02	0.04	0.02
Other Receivables	0.02	0.02	0.02	0.06	0.15	0.03
Receivables	0.02	0.02	1	0.08	0.18	0.09
Inventory	-	-	-	0.16	0.04	0.11
Prepaid Expenses	0.06	0.01	0.01	0.01	0.03	0.05
Restricted Cash	-	0.15	-	-	-	-
Other Current Assets	-	-	-	0.05	0.03	0.02
Total Current Assets	0.2	0.6	1.34	1.59	4.69	0.78
Property, Plant & Equipment	-	-	-	0.1	0.12	0.11
Goodwill	-	-	6.24	10.47	4.59	4.29
Other Intangible Assets	0.56	0.6	4.53	7.35	4.29	5.2
Other Long-Term Assets	0	-	-	-	-	-
Total Assets	0.76	1.2	12.11	19.52	13.69	10.38
Accounts Payable	0.34	0.45	0.53	0.25	0.35	0.53
Accrued Expenses	0.33	0.45	0.25	0.19	0.21	0.6
Short-Term Debt	-	-	-	-	-	2.62
Current Portion of Long-Term Debt	1.4	1.77	1.42	-	-	0.4
Current Portion of Leases	-	-	-	0.04	0.06	0.04
Current Income Taxes Payable	-	-	-	-	-	0.12
Total Current Liabilities	2.07	2.66	2.2	0.48	0.62	4.32
Long-Term Debt	-	-	-	0.79	1.03	-
Long-Term Leases	-	-	-	0.04	0.04	0.05
Long-Term Deferred Tax Liabilities	-	-	1.01	1.25	1	1.47
Other Long-Term Liabilities	-	-	0.07	0.1	0.09	0.08
Total Liabilities	2.07	2.66	3.28	2.66	2.78	5.92
Common Stock	34.05	33.21	31.22	30.61	21.83	13.22
Retained Earnings	-39.1	-38.3	-25.12	-19.4	-15.86	-11.48
Comprehensive Income & Other	3.57	3.38	2.74	5.66	3.68	1.24
Total Common Equity	-1.48	-1.7	8.84	16.87	9.66	2.98
Minority Interest	0.17	0.24	-	-	1.26	1.48
Shareholders' Equity	-1.31	-1.47	8.84	16.87	10.91	4.46
Total Liabilities & Equity	0.76	1.2	12.11	19.52	13.69	10.38
Total Debt	1.4	1.77	1.42	0.87	1.13	3.12
Net Cash (Debt)	-1.27	-1.34	-1.09	0.43	3.28	-2.61
Net Cash Growth	-	-	-	-86.91%	-	-
Net Cash Per Share	-0.01	-0.02	-0.02	0.01	0.16	-0.26
Filing Date Shares Outstanding	107.73	104.69	50.8	49.48	48.62	20.61
Total Common Shares Outstanding	107.73	88.17	50.8	48.69	34.52	11.9
Working Capital	-1.87	-2.07	-0.86	1.11	4.07	-3.54
Book Value Per Share	-0.01	-0.02	0.17	0.35	0.28	0.25
Tangible Book Value	-2.04	-2.31	-1.94	-0.96	0.78	-6.51
Tangible Book Value Per Share	-0.02	-0.03	-0.04	-0.02	0.02	-0.55
Machinery	-	-	-	0.05	0.05	0.03

Source: S&P Capital IQ. Standard template. Financial Sources.